- Home
- CTS vs SYRE Comparison
CTS vs SYRE Comparison
Compare CTS & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTS
- SYRE
- Stock Information
- Founded
- CTS 1896
- SYRE 2013
- Country
- CTS United States
- SYRE United States
- Employees
- CTS N/A
- SYRE N/A
- Industry
- CTS Electrical Products
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- CTS Technology
- SYRE Health Care
- Exchange
- CTS Nasdaq
- SYRE Nasdaq
- Market Cap
- CTS N/A
- SYRE 1.2B
- IPO Year
- CTS N/A
- SYRE 2016
- Fundamental
- Price
- CTS $42.14
- SYRE $17.94
- Analyst Decision
- CTS
- SYRE Strong Buy
- Analyst Count
- CTS 0
- SYRE 8
- Target Price
- CTS N/A
- SYRE $51.50
- AVG Volume (30 Days)
- CTS 146.3K
- SYRE 664.6K
- Earning Date
- CTS 04-30-2025
- SYRE 05-08-2025
- Dividend Yield
- CTS 0.38%
- SYRE N/A
- EPS Growth
- CTS N/A
- SYRE N/A
- EPS
- CTS 1.89
- SYRE N/A
- Revenue
- CTS $515,770,999.00
- SYRE N/A
- Revenue This Year
- CTS $5.31
- SYRE N/A
- Revenue Next Year
- CTS $6.01
- SYRE N/A
- P/E Ratio
- CTS $22.16
- SYRE N/A
- Revenue Growth
- CTS N/A
- SYRE N/A
- 52 Week Low
- CTS $41.23
- SYRE $16.71
- 52 Week High
- CTS $59.68
- SYRE $40.84
- Technical
- Relative Strength Index (RSI)
- CTS 38.65
- SYRE 43.06
- Support Level
- CTS $41.80
- SYRE $16.71
- Resistance Level
- CTS $44.08
- SYRE $19.50
- Average True Range (ATR)
- CTS 0.93
- SYRE 1.28
- MACD
- CTS 0.23
- SYRE 0.07
- Stochastic Oscillator
- CTS 31.93
- SYRE 42.86
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.